RIBOLIFE-B (06938) has announced that the overall coordinators, acting on behalf of the international underwriters, fully exercised the over-allotment option described in the prospectus on Thursday, February 5, 2026. This involved a total of 4.7414 million H shares, representing approximately 15% of the total number of shares initially available under the global offering before any over-allotment option was exercised, taking into account the full exercise of the share placement adjustment option. The additional shares will be issued and allotted by the company at HKD 57.97 per H share. These shares will be used to cover over-allotments in the international offering. Furthermore, the stabilization period for the global offering ended on Thursday, February 5, 2026, which marked the 30th day after the deadline for the Hong Kong public offering application. During the stabilization period, the stabilizing agent did not conduct any market transactions in H shares for price stabilization purposes.